Recursion Pharmaceuticals, Inc.RXRXNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank0
3Y CAGR-10.2%
5Y CAGR-54.5%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
-10.2%/yr
Annual compound
5Y CAGR
-54.5%/yr
Recent acceleration
Percentile
P0
Near historical low
vs 5Y Ago
0x
Contraction
Streak
2 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 15.60 | -32.9% |
| 2024 | 23.25 | -40.3% |
| 2023 | 38.94 | +80.8% |
| 2022 | 21.53 | -91.9% |
| 2021 | 264.31 | -67.0% |
| 2020 | 802.16 | -53.2% |
| 2019 | 1712.76 | - |